[國考申覆] 醫學(一) 72
72 治療類風濕性關節炎的生物製劑如抗腫瘤壞死因子 α 抗體(anti-TNF-α
antibodies)及人類腫瘤壞死因子受體蛋白質分子(recombinant human TNF receptor, etanercept),效果顯著,
但罹患下列何種疾病的機率增加?
A.人類免疫不全病毒感染(human immunodeficiency virus infection)
B.結核病(tuberculosis)
C.多發性硬化症(multiple sclerosis)
D.植入物抗宿主疾患(graft-versus-host disease)
正解:B
建議解答:B C
資料:
http://www.neurology.org/content/57/10/1885.short
We report a patient with new onset MS closely associated with the initiation
of anti-TNF therapy for juvenile rheumatoid arthritis. It is possible that
the inhibition of TNF triggered MS in this individual.
標題很直接就下這個了
不知道paper的申覆空間夠不夠?
這篇文章被引用了207次
--
※ 發信站: 批踢踢實業坊(ptt.cc)
◆ From: 140.112.125.33
推
07/31 16:59, , 1F
07/31 16:59, 1F
→
07/31 17:15, , 2F
07/31 17:15, 2F
→
07/31 17:29, , 3F
07/31 17:29, 3F
推
07/31 19:40, , 4F
07/31 19:40, 4F
推
07/31 20:18, , 5F
07/31 20:18, 5F
※ 編輯: tniopkcalb 來自: 61.230.120.149 (08/01 01:24)